logo BDSP

Base documentaire

  1. Fulltext. Economic evaluation of rotavirus vaccinations in finland : Randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine.

    Article - En anglais


    The cost-benefit ratio of tetravalent rhesus rotavirus vaccine (RRV-TV) in Finland for prevention of rotavirus gastroenteritis was assessed in a randomized, double-blind, placebo-controlled trial.

    Costs related to vaccination, side effects, and gastroenteritis were identified.

    Children received RRV-TV (n=1,191) or placebo (n=1,207) at 2,3, and 5 months of age with other infant vaccinations.

    Prospective follow-up averaged 1.0 years per child.

    An intention-to-treat analysis was performed from the perspective of society.

    Nine cases of severe rotavirus gastroenteritis occurred in the RRV-TV group, versus 100 in the placebo group (P<. 0001) ; mean cost per vaccinated child was 4 Finnish marks (FIM) in the RRV-TV group, versus 203 FIM in the placebo group.

    Side effects with related costs occurred after 11% and 7% of doses in the RRV-TV group and placebo group, respectively (P<. 001) ; mean cost per child was 89 FIM vs. 75 FIM.

    The break-even cost (i.e., net benefit, excluding cost of vaccine) of RRV-TV in prevention of severe rotavirus gastroenteritis was 109 FIM (U.S. $19.60) per child.

    Mots-clés Pascal : Rotavirus, Reoviridae, Virus, Gastroentérite, Immunoprophylaxie, Vaccin associé, Vaccination, Finlande, Europe, Prévention, Analyse avantage coût, Efficacité, Toxicité, Effet secondaire, Enfant, Homme, Virose, Infection, Economie santé, Appareil digestif pathologie, Estomac pathologie, Intestin pathologie

    Mots-clés Pascal anglais : Rotavirus, Reoviridae, Virus, Gastroenteritis, Immunoprophylaxis, Mixed vaccine, Vaccination, Finland, Europe, Prevention, Cost benefit analysis, Efficiency, Toxicity, Secondary effect, Child, Human, Viral disease, Infection, Health economy, Digestive diseases, Gastric disease, Intestinal disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0400987

    Code Inist : 002B05C02F. Création : 25/01/1999.